Table 3 Laboratory results of the entire cohort at a patient’s first clinic visit
From: Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort
Risk factor | With CVD | Without CVD | P-value |
|---|---|---|---|
N = 111 | N = 298 | ||
Total cholesterol (mmol/L) | 7.8(2.1) | 8.7(2.0) | <0.001 |
Mean (SD) | |||
HDL cholesterol (mmol/L) | 1.2(0.4) | 1.3(0.4) | 0.001 |
Mean (SD) | |||
LDL-cholesterol (mmol/L) | 5.7(2.0) | 6.6(1.9) | <0.001 |
Mean (SD) | |||
Triglycerides (mmol/L) | 1.6(0.9) | 1.7(1.2) | 0.509 |
Mean (SD) | |||
TC/HDL | 7.1(3.5) | 7.0(2.7) | 0.724 |
Mean (SD) | |||
Lp (a) (mg/L)* | 349.0 | 262.6 | 0.166 |
Median (IQR) | (122.0,841.2) | (104.4,605.1) | |
Fasting blood sugar (mmol/L) | 5.4(0.6) | 5.1(0.5) | 0.001 |
Mean (SD) | |||
Lipid lowering therapy (%) | 33.3 | 25.8 | 0.139 |